Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1B | P28222 | 7/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.44 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.44 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.44 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | DRD1 | P21728 | 1/20 | 0.44 |
| ▸ | HTR2B | P41595 | 1/20 | 0.44 |
| ▸ | CCR2 | P41597 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30725930 | 0.78 | HTR1B (0.46) | HTR1BALDH1A1HSD17B10TDP1HPGD | |
| SCHEMBL27467534 | 0.78 | HTR1B (0.46) | HTR1BALDH1A1HSD17B10TDP1HPGD | |
| SCHEMBL2945 | 0.78 | ALDH1A1 (0.47) | HTR1BALDH1A1HSD17B10TDP1HPGD | |
| SCHEMBL822708 | 0.78 | HTR1B (0.46) | HTR1BALDH1A1HSD17B10TDP1HPGD | |
| Hydrogen Sulfide SCHEMBL28001728 | 0.77 | HTR1B (0.44) | HTR1BALDH1A1HSD17B10TDP1HPGD | |
| SCHEMBL408356 | 0.75 | HTR1B (0.43) | HTR1BALDH1A1HSD17B10TDP1HPGD | |
| SCHEMBL442767 | 0.74 | HTR1B (0.54) | HTR1BALDH1A1HSD17B10TDP1HPGD | |
| SCHEMBL29577853 | 0.74 | HTR1B (0.54) | HTR1BALDH1A1HSD17B10TDP1HPGD | |
| SCHEMBL4289478 | 0.74 | HTR1B (0.59) | HTR1BALDH1A1HSD17B10TDP1HPGD | |
| SCHEMBL1306414 | 0.74 | HTR1B (0.42) | HTR1BALDH1A1HSD17B10TDP1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12011490-B2 | Dental photocurable composition excellent in operability and storage stability | SHOFU INC. (JP) | 2024-06-18 | — | — | US | disclosed |
| CN-113402657-B | Photopolymerization initiator containing aryl iodonium salt for dental photocurable composition | 株式会社松风 | 2024-06-11 | — | — | CN | disclosed |
| EP-3888616-B1 | DENTAL PHOTOCURABLE COMPOSITION EXCELLENT IN COLOR TONE SELECTIVITY | SHOFU INC (JP) | 2024-05-15 | — | — | EP | disclosed |
| CN-112470551-B | Sealing agent for organic electroluminescent display element | 电化株式会社 | 2024-05-14 | — | — | CN | disclosed |
| CN-113227159-B | Composition and method for producing the same | 电化株式会社 | 2024-04-19 | — | — | CN | disclosed |
| CN-110007557-B | Curable composition, film, optical film, light-emitting display element panel, and light-emitting display device | 东京应化工业株式会社 | 2024-04-12 | — | — | CN | disclosed |
| CN-108957956-B | Curable composition, cured product, cured film, display panel, and method for producing cured product | 东京应化工业株式会社 | 2024-04-02 | — | — | CN | disclosed |
| EP-3881818-B1 | DENTAL PHOTOCURABLE COMPOSITIONS COMPRISING PHOTOPOLYMERIZATION INITIATOR COMPRISING AN ARYLIODONIUM SALT | SHOFU KK (JP) | 2024-03-06 | — | — | EP | disclosed |
| CN-117510794-A | Composition and method for producing the same | 电化株式会社 | 2024-02-06 | — | — | CN | disclosed |
| US-20240027901-A1 | PHOTOACID GENERATOR, AND PHOTOSENSITIVE COMPOSITION USING SAME | SAN-APRO LTD. (JP) | 2024-01-25 | — | — | US | disclosed |
| US-20090203927-A1 | Homogeneous asymmetric hydrogenation catalyst | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-08-13 | — | — | US | disclosed |
| US-20090163723-A1 | METHOD FOR PRODUCING SULFONIUM FLUORINATED ALKYLFLUOROPHOSPHATE | SAN-APRO LIMITED (JP) | 2009-06-25 | — | — | US | disclosed |
| US-20080312191-A1 | Novel Urokinase Inhibitors | UNIVERSITEIT ANTWERPEN (BE) | 2008-12-18 | — | — | US | disclosed |
| EP-1953139-A1 | METHOD FOR PRODUCING FLUORINATED SULFONIUM ALKYLFLUOROPHOSPHATE | San-Apro Ltd. (JP) | 2008-08-06 | — | — | EP | disclosed |
| EP-1940856-A1 | NOVEL UROKINASE INHIBITORS | Universiteit Antwerpen (BE) | 2008-07-09 | — | — | EP | disclosed |
| EP-1911516-A1 | HOMOGENEOUS ASYMMETRIC HYDROGENATION CATALYST | Takasago International Corporation (JP) | 2008-04-16 | — | — | EP | disclosed |
| US-7312347-B2 | Substituted optically active disphosphine compound | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2007-12-25 | — | — | US | disclosed |
| US-20070142639-A1 | Process for production of amines | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2007-06-21 | — | — | US | disclosed |
| WO-2007045496-A1 | NOVEL UROKINASE INHIBITORS | UNIVERSITEIT ANTWERPEN (BE) | 2007-04-26 | — | — | WO | disclosed |
| US-20070073065-A1 | Substituted optically active disphosphine compound | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2007-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090203927-A1 | Homogeneous asymmetric hydrogenation catalyst | HDHD5, HHAT, HACL2 | HTR1B 2298/4885ALDH1A1 1221/4885HSD17B10 88/4885 |
| US-20070142639-A1 | Process for production of amines | SMS, CCNT1, PEAK1 | HTR1B 944/4885ALDH1A1 1001/4885HSD17B10 3582/4885 |
| US-12011490-B2 | Dental photocurable composition excellent in operability and storage stability | H1-0, CCND1, CCNT1 | HTR1B 599/4885ALDH1A1 148/4885HSD17B10 2658/4885 |
| US-20240027901-A1 | PHOTOACID GENERATOR, AND PHOTOSENSITIVE COMPOSITION USING SAME | ATIC, MAP1LC3C, TYR | HTR1B 3771/4885ALDH1A1 1152/4885HSD17B10 4401/4885 |
| US-20090163723-A1 | METHOD FOR PRODUCING SULFONIUM FLUORINATED ALKYLFLUOROPHOSPHATE | ARSA, SCO2, DOHH | HTR1B 3484/4885ALDH1A1 1481/4885HSD17B10 588/4885 |
| US-20080312191-A1 | Novel Urokinase Inhibitors | PLAU, PLAUR, SERPINE1 | HTR1B 4216/4885ALDH1A1 1620/4885HSD17B10 3591/4885 |
| US-20070073065-A1 | Substituted optically active disphosphine compound | DHPS, DOHH, DHODH | HTR1B 2969/4885ALDH1A1 277/4885HSD17B10 655/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.